News
The Duke Human Vaccine Institute plays an integral role in modernizing flu vaccines.
Duke is the only institution to receive a contract in each of the three CIVICs components, including work to design and evaluate influenza vaccine approaches, manufacture and evaluate the safety and toxicity of vaccine platforms, and conduct clinical trials for influenza vaccines.
Our Best Shot - DHVI Documentary
The Duke Human Vaccine Institute (DHVI) was featured in a WRAL-TV documentary about the coronavirus pandemic and DHVI’s efforts to combat it.
The Duke CIVICs investigators featured in the documentary include Dr. Tom Denny, Dr. Tony Moody, and Dr. Greg Sempowski. Learn more about DHVI and its efforts to develop a coronavirus vaccine.
VIDEO: What is considered good vaccine efficacy?
DHVI Investigator and director of the Duke CIVICs Vaccine Center (DCVC), Dr. Tony Moody answers questions about effectiveness of the Moderna, Pfizer and Johnson & Johnson vaccines. Dr. Moody is a Professor of Pediatrics at Duke and an experienced clinician in Pediatric Infectious Diseases.
School of Medicine Expands to RTP, January 2021
The Duke University School of Medicine is expanding into a newly-leased research center in the Research Triangle Park (RTP). The 273,000 square foot facility in the Parmer RTP research and development campus, formerly home to pharmaceutical maker GlaxoSmithKline, is currently being renovated to accommodate School of Medicine faculty, staff and labs as soon as January 2021.